The two new HIV drugs, Emtriva and Reyataz
The two new HIV drugs, Emtriva and Reyataz, will help simplify regimens...they're each given just ONCE a day.
Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir). It's well-tolerated and doesn't affect cytochrome P450 enzymes, so drug interactions aren't likely.
Emtriva is mostly excreted renally. Patients take it less often if they have a creatinine clearance < 50 mL/min.